Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4FEC

Crystal Structure of Htt36Q3H

Summary for 4FEC
Entry DOI10.2210/pdb4fec/pdb
Related3IO4 3IO6 3IOR 3IOT 3IOU 3IOV 4FE8 4FEB 4FED
DescriptorMaltose-binding periplasmic protein,Huntingtin, ZINC ION (3 entities in total)
Functional Keywordsalpha helix, loop, beta-strand hairpin, beta strand hairpin, disease protein, signaling protein
Biological sourceEscherichia coli (strain K12)
More
Cellular locationCytoplasm: P42858
Total number of polymer chains3
Total formula weight152352.64
Authors
Kim, M. (deposition date: 2012-05-30, release date: 2013-03-13, Last modification date: 2023-11-29)
Primary citationKim, M.
Beta conformation of polyglutamine track revealed by a crystal structure of Huntingtin N-terminal region with insertion of three histidine residues.
Prion, 7:221-228, 2013
Cited by
PubMed Abstract: Huntington disease is an autosomal-dominant neurodegenerative disorder caused by a polyglutamine (polyQ) expansion (> 35Q) in the first exon (EX1) of huntingtin protein (Htt). mHtt protein is thought to adopt one or more toxic conformation(s) that are involved in pathogenic interactions in cells . However, the structure of mHtt is not known. Here, we present a near atomic resolution structure of mHtt36Q-EX1. To facilitate crystallization, three histidine residues (3H) were introduced within the Htt36Q stretch resulting in the sequence of Q 7HQHQHQ 27. The Htt36Q3H region adopts α-helix, loop, β-hairpin conformations. Furthermore, we observed interactions between the backbone of the Htt36Q3H β-strand with the aromatic residues mimicking putative-toxic interactions with other proteins. Our findings support previous predictions that the expanded mHtt-polyQ region adopts a β-sheet structure. Detailed structural information about mHtt improves our understanding of the pathogenic mechanisms in HD and other polyQ expansion disorders and may form the basis for rational design of small molecules that target toxic conformations of disease-causing proteins.
PubMed: 23370273
DOI: 10.4161/pri.23807
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3 Å)
Structure validation

229380

PDB entries from 2024-12-25

PDB statisticsPDBj update infoContact PDBjnumon